RNU6-191P

Across TCGA pan-cancer cohorts, RNU6-191P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-191P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU6-191P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-191P expression acts as an unfavorable survival marker.

BLCA, KIRC, and BRCA are the cancer types where RNU6-191P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.159	0.625	.016	45	view →
KIRC	DFS	Tertile	III,IV	0.397	0.753	.013	42	view →
BRCA	DFS	Tertile	All	0.644	0.904	.010	24	view →
LGG	DFS	Tertile	All	0.213	0.739	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU6-191P–BLCA (DFS)

Open the BLCA breakdown →